Recruiting NCT07151339
Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Preeclampsia, HELLP Syndrome, Eclampsia, Kidney Disease. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Germany
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie
Overview
Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)
Primary outcome measures
- Pulse wave velocity [Time frame: 12 months]
Eligibility criteria
Inclusion criteria
- older than 18 yrs
- diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy
Exclusion criteria
- unable for informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Germany · 1 center
- University Hospital Schleswig- Holstein — Kiel
Identifiers
NCT: NCT07151339 · D557/24